ArticleThe Canadian journal of hospital pharmacy2022
Correction to "Effectiveness and Safety of Palbociclib plus Endocrine Therapy in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Real-World Results".
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.